Chemotherapy can enhance tumor immunogenicity by increasing neoantigen presentation and promoting immunogenic cell death, thereby synergizing with PD-1/PD-L1 blockade to enhance cytotoxic T-cell responses. Here, CD274 is linked to neoplasm.